Clinical trials - Press Releases

Date	Title	Company
20-Oct-2021	TB-PRACTECAL: MSF clinical trial finds short, effective and safe drug-resistant tuberculosis treatment	Médecins Sans Frontières/Doctors Without Borders (MSF)
20-Oct-2021	Conference Chair Di Morris, AstraZeneca invites you to join SMi's 10th Annual Pharmaceutical Microbiology Conference	SMi Group
20-Oct-2021	Major US hospital-based clinical trial highlights benefit of nasal decolonization to reduce ICU infections caused by Staphylococcus aureus	Destiny Pharma
20-Oct-2021	Agilex Biolabs Shares How to Select the Right Bioanalytical Tools for Immuno-oncology and Vaccines Studies - OCT Webinar	Agilex Biolabs
18-Oct-2021	Safety results from large real-world safety study in combined oral contraception published	Theramex
14-Oct-2021	Adocia’s partner Tonghua Dongbao Receives Clearance to Start Ultra-Rapid Insulin BioChaperone® Lispro Phase 3 Trial to Treat Type 1 and Type 2 Diabetes in China	Adocia
14-Oct-2021	APEIRON Biologics commences clinical COVID-19 trial with inhaled APN01	APEIRON Biologics AG
13-Oct-2021	Oxurion NV Announces First Patient Dosed in its Phase 2 Study Evaluating THR-687 for the treatment of Diabetic Macular Edema (DME)	Oxurion NV
12-Oct-2021	Medidata Rave Imaging Reaches Milestone, Supporting More Than 1,000 Clinical Studies	Medidata
11-Oct-2021	AZD7442 reduced risk of developing severe COVID-19 or death in TACKLE Phase III outpatient treatment trial	AstraZeneca
08-Oct-2021	AMZELL BV receives FDA Special Protocol Assessment for Phase 3 trial of innovative injectable treatment for infantile epileptic disease	AMZELL BV
07-Oct-2021	New Elsevier report highlights progress towards disease-modifying treatments for pancreatitis	Elsevier
06-Oct-2021	PEP-Therapy and Institut Curie announce first patients dosed in Phase I clinical trial of PEP-010 for the treatment of advanced solid tumors	PEP-Therapy
05-Oct-2021	New Analysis Presented by Janssen at United European Gastroenterology Week (UEGW) Demonstrates Long-Term Safety Profile for STELARA® (ustekinumab) in Older Patients Across Approved Indications	Janssen
30-Sep-2021	OXURION Announces Positive Results from Part A of Phase 2 Study Evaluating THR-149 for Treatment of Diabetic Macular Edema (DME)	OXURION
30-Sep-2021	LEO Pharma and Veeva Systems Partner for Patient-centric Digital Trials	LEO Pharma
30-Sep-2021	Novartis and Medicines for Malaria Venture report positive results for Phase 2b study of novel ganaplacide/lumefantrine combination in children with malaria	Novartis
29-Sep-2021	£2.7M CHALLENGE SET TO REPLACE USE OF DOGS IN DRUG TESTING	konfer
29-Sep-2021	PureTech Founded Entity Akili Announces Topline Results from Shionogi Phase 2 Study in Japan	PureTech
29-Sep-2021	First participants enrolled in Clinical Trial with Nociceptin/Orphanin peptide receptor (NOP) agonist	Grünenthal